Taking into consideration the repression of adipocyte ANGPTL4 mRNA by insulin [35,46], the upregulation of ANGPTL4 in insulin resistance may contribute to the postprandial dyslipidemia in insulin-resistant individuals via inhibition of LPL. The gene discussed is INS; the disease is metabolic syndrome.